Latest topics
» POOFness for JAN 20: We Can Help Heal The World While We Soak You For Donations
Today at 1:22 am by 4-truth

» LIVE #LunarEclipse: #SuperBloodMoon
Yesterday at 10:06 pm by LadyDragon

» #LIVE #QANON #LadyDragon + #SundayMorningFutures #MariaBartiromo @potus
Yesterday at 6:59 pm by LadyDragon

» Earth, The Giant Ancient Mine, Fake Volcanoes, the Bosnian Pyramid and Petra
Yesterday at 4:46 pm by Consciousness Of Economic

» Nuclear News - SHOCKING !! Fukushima Meltdown Cover-up & Proof Nuclear University's Are Evil
Yesterday at 4:46 pm by Consciousness Of Economic

» Fake News & The Psychopaths That Create Them Exposed
Yesterday at 4:45 pm by Consciousness Of Economic

» Hoax 1850 Historical Interviews
Yesterday at 4:44 pm by Consciousness Of Economic

» Jeff and Dane Wiggington - NASA Satellite Pics PROVE Disastrous Weather Eng
Yesterday at 4:43 pm by Consciousness Of Economic

» The Collective Vs The United Nations #WWG1WGA
Yesterday at 4:43 pm by Consciousness Of Economic

» THOUSANDS MORE ARE COMING AND MEXICO IS HELPING THEM - MIGRANT CARAVAN UPDATE WITH ALEX BACKMAN
Yesterday at 4:42 pm by Consciousness Of Economic

» Historic Timeline Based on Historic Sites & Artefacts Instead of Blind Belief in the Quakademia
Yesterday at 4:41 pm by Consciousness Of Economic

» Greg Hunter - Weekly News Wrap-Up 1.18.19
Yesterday at 4:40 pm by Consciousness Of Economic

» part 39 Star Forts or Ancient Power Stations, Star forts from all around the globe, Documentary
Yesterday at 4:40 pm by Consciousness Of Economic

» What are Star Forts?
Yesterday at 4:39 pm by Consciousness Of Economic

» Geoengineering Watch Global Alert News, January 19, 2019, #180 ( Dane Wigington )
Yesterday at 4:38 pm by Consciousness Of Economic

» Genghis Khan from the Fairyland - p 26 / When the Survivors of Atlantis Wake Up
Yesterday at 4:37 pm by Consciousness Of Economic

» We The People Vs The CFR United Nations #TheQllective #2Q19
Yesterday at 4:36 pm by Consciousness Of Economic

» THE FLU SHOT VIDEO THAT EVERYONE NEEDS TO SEE AND SHARE....
Yesterday at 4:34 pm by Consciousness Of Economic

» #LIVE #QANON #LadyDragon + #Meditation with #JaredRand Jan 20 @potus
Yesterday at 4:21 pm by LadyDragon

» Does Cloud Therapy allow Dimension Hopping?
Yesterday at 2:03 pm by Lenny Thyme

»  The Year of the Dragon, “Let Us Pray...”
Yesterday at 1:01 pm by PurpleSkyz

» Breaking: REPORT: Roundup Will Be Pulled From Shelves in Costco in Spring 2019!
Yesterday at 2:03 am by PurpleSkyz


CLICK THE SUBSCRIBE BUTTON BELOW TO RECEIVE OUR DAILY NEWSLETTER

A 2ND EMAIL COMPLETES THE ACTIVATION PROCESS




CLICK THE PURPLE BUTTON TO VIEW OUR LATEST POSTS




CURRENT MOON



CHARITY WATER PROJECT
100% OF DONATIONS GOES TO PROVIDING CLEAN WATER TO THOSE IN NEED


www.charitywater.org

1 in 10 people lack access to clean water. We’re on a mission to change that. Here’s how.



Private donors cover our operating costs so 100% of your donation will bring clean water to people in need.

www.charitywater.org




You are not connected. Please login or register

Out Of Mind » POISON PLANET » VACCINE TRUTHS: MEDICAL INDUSTRY LIES » ABOUT TIME!! ~ GlaxoSmithKline to Quit Paying Doctors for Promotional Talks

ABOUT TIME!! ~ GlaxoSmithKline to Quit Paying Doctors for Promotional Talks

Go down  Message [Page 1 of 1]

PurpleSkyz

avatar
Admin
GlaxoSmithKline to Quit Paying Doctors for Promotional Talks
Charles Ornstein, ProPublica
In a major departure from industry practice, GlaxoSmithKline, the sixth-largest global drug maker, announced Tuesday that it will no longer hire doctors to promote its drugs.
(Photo: Ian Wilson/cc/flickr) The company also will stop tying compensation for sales representatives to the number of prescriptions written for drugs they market. The changes will be made worldwide over the next two years.
The New York Times broke the news late Monday. But the company said it will continue to pay doctors for research, consulting and "market research." It will also continue to provide unsolicited funding for continuing medical education activities run by "independent" groups.
Glaxo's move is more evolutionary than revolutionary, the last step in a dramatic reduction in its spending on physician speakers in recent years. Some competitors have shown no signs of letting up.
Glaxo first began reporting its payments to doctors in 2009. During the last nine months of that year, it spent an average of $15.4 million per quarter on paid promotional talks, according to ProPublica's Dollars for Docs database of pharmaceutical company payments to physicians.
Spending on promotional speaking dropped to $13.2 million per quarter in 2010, to $6 million per quarter in 2011 and to $2.5 million in each of the first three quarters of 2012, data show.
That's an overall decline of more than 80 percent.
By comparison, Forest Labs, a much smaller drug maker, spent more than $9 million a quarter on physician speakers last year.
Earlier this year, Glaxo spokeswoman Mary Anne Rhyne wrote in an email to ProPublica that the company's promotional spending tracks with new drugs or new uses for existing products. "That activity has been relatively low in the past year, so spending for speaker programs has been lower, too," she said.
Glaxo's well-known drugs include Advair for asthma, Lovaza for high triglyceride levels and Avodart for prostate enlargement. It also makes the diabetes drug Avandia, which was subjected to tough restrictions from the FDA in 2010 because of concerns about heart risks. The FDA recently eased those restrictions after reconsidering the risks.
The top recent speaking programs for Glaxo involved Advair and Jalyn, which treats problems with urination for men with enlarged prostates, Rhyne said earlier this year.
In an email this morning, Rhyne said the company had taken a number of steps to change its sales and marketing practices in recent years. "This is the next step of that evolution," she wrote.
Pharmaceutical companies have faced increased pressure as their payments to doctors have been made public, in part through efforts like Dollars for Docs. More than 15 drug companies report their payments to doctors for speaking, consulting, meals, travel and research under Corporate Integrity Agreements with the federal government that arose from settling lawsuits alleging unlawful marketing.
Beginning next year, every drug and medical device company will have to make payments to doctors public under the Physician Payment Sunshine Act, a provision of the 2010 Affordable Care Act. Some experts have said that such transparency will discourage doctors from accepting payments, a contention supported by some doctors themselves.
"Many people have wondered, what difference will it make?" asked Susan Chimonas, a research scholar at the Center on Medicine as a Profession at Columbia University. "Will it clean up practices, or just allow the status quo to continue so long as there is transparency? Glaxo's move is giving us an early answer - and reason for optimism. The saying about sunlight being the best disinfectant - that's exactly what we're seeing here. The Sunshine law is working."
The American Medical Student Association has called on medical schools to adopt strict policies limiting pharmaceutical company interactions with faculty. And some doctors themselves are calling on peers to be transparent with patients. They have created a website called Who's My Doctor: The Total Transparency Manifesto.
Still, some doctors continue to accept hundreds of thousands of dollars in payments from the pharmaceutical industry.
Glaxo's chief executive Andrew Witty told the Times yesterday that the changes were being made "to try and make sure we stay in step with how the world is changing. We keep asking ourselves, are there different ways, more effective ways of operating than perhaps the ways we as an industry have been operating over the last 30, 40 years?"
"Today we are outlining a further set of measures to modernize our relationship with healthcare professionals," Witty said in a press release. "These are designed to bring greater clarity and confidence that whenever we talk to a doctor, nurse or other prescriber, it is patients' interests that always come first. We recognize that we have an important role to play in providing doctors with information about our medicines, but this must be done clearly, transparently and without any perception of conflict of interest."
The British drug maker has faced intense criticism of its business practices. In July 2012, Glaxo agreed to pay $3 billion, a record, to settle criminal and civil claims "arising from the company's unlawful promotion of certain prescription drugs, its failure to report certain safety data, and its civil liability for alleged false price reporting practices," the& U.S. Justice Department announced.
Glaxo also agreed to plead guilty to two counts of introducing misbranded drugs, Paxil and Wellbutrin, into interstate commerce and one count of failing to report safety data about Avandia to the Food and Drug Administration.
The company also has been under fire for bribing doctors in China to prescribe its drugs and using travel agencies to cover it up. In July, the company said that some senior executives in China appeared to have violated Chinese law.
Amid these troubles, Glaxo has also been more transparent than some of its peers. In October 2012, the company said it would disclose its clinical trial data to researchers — another industry first.
"We're increasingly realizing that the more you can make this an open enterprise, the more likely you are to be able to get an advance which allows you to make a medicine," Dr. Patrick Vallance, president of pharmaceuticals research and development at GlaxoSmithKline, told The New York Times. "I think we recognize that you learn as much about the medicine after it's launched as you knew before."
Look up your doctor's financial ties to pharmaceutical companies here.


Thanks to: http://www.commondreams.org



  

Back to top  Message [Page 1 of 1]

Permissions in this forum:
You cannot reply to topics in this forum